Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine–Naïve Adults 18 Through 49 Years of Age]

Category & Conditions:
Vaccine-related Conditions
Medicine:
PF-06482077
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7471008
Open Plain Language Summary Result:Click here